The SGLT2 Inhibitor, Empagliflozin, Attenuates Some Markers of Renal Fibrosis without Improving Albuminuria in Diabetic Db/Db Mice

被引：0
|
作者：
Gallo, Linda A. [1 ]
Ward, Micheal S. [1 ]
Fotheringham, Amelia K. [1 ]
Zhuang, Aowen [1 ]
Koepsell, Hermann [2 ]
Vallon', Volker [3 ,4 ]
Pollock, Carol [5 ]
Panchapakesan, Usha [5 ]
Forbes, Josephine M. [1 ]
机构：
[1] Univ Queensland, Mater Res Inst, Woolloongabba, Qld, Australia
[2] Univ Wurzburg, Wurzburg, Germany
[3] Univ Calif San Diego, La Jolla, CA 92093 USA
[4] VA San Diego Healthcare Syst, San Diego, CA USA
[5] Univ Sydney, Kolling Inst Med Res, St Leonards, NSW, Australia
来源：
FASEB JOURNAL | 2016年 / 30卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
740.18
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The Sodium Glucose Cotransporter-2 (SGLT-2) Inhibitor Empagliflozin Improves Insulin Sensitivity in db/db Mice in a Dose-Dependent Manner
    Kern, Matthias
    Kloeting, Nora
    Mayoux, Eric
    Mark, Michael
    Klein, Thomas
    Blueher, Matthias
    DIABETES, 2012, 61 : A262 - A263
  • [42] Effects of Combining Linagliptin Treatment with BI-38335, A Novel SGLT2 Inhibitor, on Pancreatic Islet Function and Inflammation in db/db Mice
    Chen, L.
    Klein, T.
    Leung, P. S.
    CURRENT MOLECULAR MEDICINE, 2012, 12 (08) : 995 - 1004
  • [43] Combined treatment with DPP-4 inhibitor linagliptin and SGLT2 inhibitor empagliflozin attenuates neointima formation after vascular injury in diabetic mice
    Takahashi, Hiroyuki
    Nomiyama, Takashi
    Terawaki, Yuichi
    Horikawa, Takeshi
    Kawanami, Takako
    Hamaguchi, Yuriko
    Tanaka, Tomoko
    Motonaga, Ryoko
    Fukuda, Takashi
    Tanabe, Makito
    Yanase, Toshihiko
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2019, 18
  • [44] SGLT2 inhibitor empagliflozin ameliorates tubulointerstitial fibrosis in DKD by downregulating renal tubular PKM2
    Xiang Cai
    Huanyi Cao
    Meijun Wang
    Piaojian Yu
    Xiaoqi Liang
    Hua Liang
    Fen Xu
    Mengyin Cai
    Cellular and Molecular Life Sciences, 82 (1)
  • [45] SGLT2 INHIBITOR PREVENTS RENAL FIBROSIS AFTER RENAL ISCHEMIA/REPERFUSION INJURY IN MICE
    Nishiyama, Akira
    Xhang, Yifan
    Nakano, Daisuke
    JOURNAL OF HYPERTENSION, 2018, 36 : E22 - E22
  • [46] The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats
    Steven, Sebastian
    Oelze, Matthias
    Hanf, Alina
    Kroeller-Schoen, Swenja
    Kashani, Fatemeh
    Roohani, Siyer
    Welschof, Philipp
    Kopp, Maximilian
    Goedtel-Armbrust, Ute
    Xia, Ning
    Li, Huige
    Schulz, Eberhard
    Lackner, Karl J.
    Wojnowski, Leszek
    Bottari, Serge P.
    Wenzel, Philip
    Mayoux, Eric
    Muenzel, Thomas
    Daiber, Andreas
    REDOX BIOLOGY, 2017, 13 : 370 - 385
  • [47] The SGLT2 Inhibitor Empagliflozin Improves the Primary Diabetic Complications in ZDF Rats
    Hanf, Alina
    Steven, Sebastian
    Oelze, Matthias
    Kroeller-Schoen, Swenja
    Kashani, Fatemeh
    Roohani, Siyer
    Welschof, Philipp
    Kopp, Maximilian
    Goedtel-Armbrust, Ute
    Xia, Ning
    Li, Huige
    Schulz, Eberhard
    Lackner, Karl J.
    Wojnowski, Leszek
    Bottari, Serge P.
    Wenzel, Philip
    Mayoux, Eric
    Muenzel, Thomas
    Daiber, Andreas
    FREE RADICAL BIOLOGY AND MEDICINE, 2017, 112 : 112 - 113
  • [48] MODULATION OF SYMPATHETIC NERVE ACTIVITY BY SGLT2 INHIBITOR EMPAGLIFLOZIN IN DIABETIC RABBITS
    Gueguen, Cindy
    Burke, Sandra L.
    Barzel, Benjamin
    Lim, Kyungjoon
    Eikelis, Nina
    Watson, Anna Md
    Jha, Jay C.
    Jackson, Kristy L.
    Sata, Yusuke
    Lambert, Gavin W.
    Jandeleit-Dahm, Karin Am
    Cooper, Mark E.
    Thomas, Merlin C.
    Head, Geoffrey A.
    JOURNAL OF HYPERTENSION, 2021, 39 : E24 - E24
  • [49] SGLT2 INHIBITOR ATTENUATES ISCHEMIA REPERFUSION RENAL INJURY
    Lee, Kang Wook
    Choi, Hyun-Su
    Chang, Yoon Kyung
    Jeong, Jin Young
    Chung, Sarah
    Ham, Young Rok
    Na, Ki Ryang
    Choi, Dae Eun
    Jeon, Jae Woong
    TRANSPLANT INTERNATIONAL, 2015, 28 : 437 - 437
  • [50] EFFECTIVE REDUCTION OF DIABETIC NEPHROPATHY INDUCED ALBUMINURIA WITH SGLT2 INHIBITOR MONOTHERAPY
    Shakoor, Muhammad
    Shah, Ankur
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 77 (04) : 650 - 650
12345